Published: 8 November 2019
Author(s): Domenico Trombetta, Paola Parente, Tiziana Pia Latiano, Federico Pio Fabrizio, Lucia Anna Muscarella
Section: Letter to the Editor

Cholangiocarcinoma (CCA) are a heterogeneous group of malignant epithelial neoplasia arising from the epithelial cell lining the intra and extra-hepatic biliary tree, which represent the second most common liver malignancy after hepatocellular carcinoma and almost 3% of all gastrointestinal cancers [1]. Most of CCA occurs occasionally despite the well-established risk factors [2] and surgery is the only curative option for early-stage patients. Late diagnosis compromises the effective therapeutic options, which are mainly based on surgical resection.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.